| Species |
Human |
| Protein Construction |
VSIG8 (Val22-Gly263)_x000D_
Accession # P0DPA2 |
His |
| N-term |
C-term |
|
| Purity |
> 95% as determined by Bis-Tris PAGE |
| Endotoxin Level |
Less than 1EU per μg by the LAL method. |
| Expression System |
HEK293 |
| Theoretical Molecular Weight |
28.2 kDa |
| Apparent Molecular Weight |
Due to glycosylation, the protein migrates to 29-32 kDa based on Bis-Tris PAGE result. |
| Formulation |
Lyophilized from 0.22μm filtered solution in 20mM NaAc,150mM NaCl (pH 4.0). |
| Reconstitution |
Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in 20mM NaAc,150mM NaCl (pH 4.0). |
| Storage & Stability |
Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles. |
| Target Background |
VSIG8 (V-Set And Immunoglobulin Domain Containing 8) is a Protein Coding gene. Diseases associated with VSIG8 include Retinitis Pigmentosa 30 and Monilethrix. An important paralog of this gene is CXADR.The present work helps characterize the component V-set and immunoglobulin domain containing 8 (VSIG8) in hair shaft and nail plate to assist in understanding its possible relation to disease states. |
| Synonyms |
VSIG8; C1orf204 |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
